BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

United States, BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

The best Articles in our Network

France

Riot secures $30M to expand Employee-Focused Cybersecurity Suite

Canada

FLiiP secures $4.4M CAD to expand Fitness Industry Management Software in North America and Europe

Canada

Mangrove Lithium secures $50.4M CAD to build North America’s First Electrochemical Lithium Refining Plant in British Columbia

United Kingdom

Prosper raises €4.7M to expand AI-Powered Wealth Management Platform

France

Alice & Bob from France secures €100M to build Fault-Tolerant Quantum Computers

France

Formance raises $21M to build scalable Fintech Infrastructure

Previous

Next